MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
$6,880,755
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from the issuance o...
Accounts payable and accrued lia...
Net proceeds from the issuance o...
Others
Negative Cash Flow Breakdown
Net loss
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Net loss
-3,027,002
-2,869,949
-2,198,991
-1,000,758
Depreciation expense
27,685
27,685
27,685
27,685
Stock-based compensation to employees, directors and consultants
77,199
623,811
9,300
31,514
Prepaid expenses and other current assets
-390,372
67,665
714,128
-35,943
Accounts payable and accrued liabilities
1,393,229
-511,176
1,139,840
-265,823
Net cash used in operating activities
-1,138,517
-2,797,294
-1,736,294
-1,171,439
Net proceeds from the issuance of common stock
669,272
794,844
-
-
Net proceeds from the issuance of preferred stock
-
-
0
4,035,000
Net proceeds from the issuance of preferred stock, net
7,350,000
0
-
-
Net cash provided by financing activities
8,019,272
794,844
0
0
Net increase in cash
6,880,755
-2,002,450
-1,736,294
-1,171,439
Cash at beginning of period
710,689
4,449,433
4,449,433
3,948,658
Cash at end of period
7,591,444
710,689
2,713,139
4,449,433
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
ALZN Cash Flow Sankey Diagram
Sankey diagram visualizing ALZN cash flow for the period
Net proceeds from
the issuance of...
$7,350,000
(82.16%↑ Y/Y)
Net proceeds from
the issuance of...
$669,272
Net cash provided by
financing activities
$8,019,272
(98.74%↑ Y/Y)
Net increase in cash
$6,880,755
(311.48%↑ Y/Y)
Canceled cashflow
$1,138,517
Accounts payable and
accrued liabilities
$1,393,229
(299.72%↑ Y/Y)
Prepaid expenses and
other current assets
-$390,372
(-592.65%↓ Y/Y)
Stock-based compensation to
employees, directors and...
$77,199
(79.94%↑ Y/Y)
Depreciation expense
$27,685
(0.00%↑ Y/Y)
Net cash used in
operating activities
-$1,138,517
(51.81%↑ Y/Y)
Canceled cashflow
$1,888,485
Net loss
-$3,027,002
(-12.00%↓ Y/Y)
Buy us a coffee
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)